Hereditary Breast and Ovarian Cancer

Hereditary Breast and Ovarian Cancer

Molecular Mechanism and Clinical Practice

Miki, Yoshio; Aoki, Daisuke; Nakamura, Seigo

Springer Verlag, Singapore

10/2022

324

Mole

Inglês

9789811645235

15 a 20 dias

625

Descrição não disponível.
1 History, Advancements, and Future Strategies.- 2 Molecular basis of BRCA1 and BRCA2 - Homologous recombination deficiency and tissue-specific carcinogenesis.- 3 Genetic Testing.- 4 Variants of uncertain significances in hereditary breast and ovarian cancer.- 5 Genetic counseling in Hereditary Breast and Ovarian Cancer.- 6 Hereditary Breast Cancer.- 7 Hereditary Ovarian Cancer.- 8 Risk-Based Breast Cancer Screening.- 9 Chemoprevention for Breast Cancer.- 10 Chemoprevention for Ovarian Cancer.- 11 Risk-Reducing Mastectomy (RRM).- 12 Risk-reducing salpingo-oophorectomy (RRSO).- 13 Panel Testing.- 14 Germline Findings through Precision Oncology for Ovarian Cancer.- 15 Germline Findings from Genetic Testing for Breast Cancer.- 16 Hereditary Breast and Ovarian Cancer (HBOC) Database.- 17 Ethical Issues: Overview in Genomic analysis and Clinical Context.- 18 PARP Inhibitors-Mechanism of action.- 19 PARPi - Efficacy in Hereditary Breast Cancer.- 20 Efficacy of Poly ADP-Ribose Polymerase Inhibitors for Hereditary Ovarian Cancer.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Breast Cancer;Ovarian Cancer;Precision Medicine;Oncology;Hereditary Breast and Ovary Cancer;HBOC;Gynecological Oncology;Chemoprevention;Genetic Testing;Risk Reduction;Genetic Counseling;VUS;Variant of unknown significance;RRM;RRSO;Parp Inhibitor